HHS Launches a National Biotechnology and Biomanufacturing Initiative

The U.S. Department of Health and Human Services (HHS) has launched a National Biotechnology and Biomanufacturing Initiative to help drive research and development, improve access to quality federal data, grow domestic manufacturing capacity, expand market opportunities for biobased products, train a diverse and skilled workforce, streamline regulatory processes for products of biotechnology, advance biosafety and biosecurity to reduce risk, protect the U.S. biotechnology ecosystem and build a thriving and secure global bioeconomy with partners and allies.

HHS intends to leverage biotechnology and biomanufacturing to achieve medical breakthroughs, reduce the overall burden of disease and improve health outcomes. The organization will lead the U.S. government in strategically advancing biosafety and biosecurity innovation as part of a growing bioeconomy to ensure biotechnology research and development and biomanufacturing infrastructure break new ground while reducing risk.